Brain Shunt Recall: Gravity Compensating Accessory

The FDA posted a notice yesterday about a Class 1 recall issued by Integra NeuroSciences for their Gravity Compensating Accessory (High Pressure Range), part of a brain shunt system used to prevent too much fluid from being redirected from the brain to the abdomen while sitting or standing.

The device is being recalled because it may leak cerebrospinal fluid, which could cause inflammation of the spinal cord, brain or abdominal membranes, failure of the shunt system or exert pressure on the wound created by implantation of the device.

 
The product is marketed as the “Gravity Compensating Accessory (GCA), High Pressure Range, Sterile, Single Use, Prescription Use (Rx) only”. The recalled devices were distributed between February 22, 2008 through June 1, 2008.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

A brain shunt is a hole or passage which redirects fluid from the brain to the abdomen, and the Gravity Compensating Accessory (GCA) is designed to counterbalance the effect of gravity within the shunt system. It prevents the sudden loss of too much cerebrospinal fluid from the central nervous system when an individual stands or sits.

The Gravity Compensating Accessory comes in three ranges of pressure or flow resistance, low, medium and high. It consists of stainless steel balls that change flow resistance through a ball and cone mechanism.

The FDA posted notice of the brain shunt device recall on their MedWatch page on December 11, 2008, notifying hospital surgical and neurological healthcare professions about the problems with the product.

The recall was first initiated by Integra NeuroSciences on October 3, 2008 and the company has sent letters directly to hospitals and other customers to directly notify doctors who may have implanted the device.

The brain shunt accessory recall was classified as a Class 1 recall, which indicates that use of the product poses a reasonable probability of serious injury or death.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

EU Launches Investigation Into Ozempic Vision Loss Problems
EU Launches Investigation Into Ozempic Vision Loss Problems (Posted yesterday)

Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.